本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Stoke Therapeutics, Inc.

11.90
+0.15001.28%
盤後11.900.00000.00%19:48 EDT
成交量:67.80萬
成交額:806.43萬
市值:6.50億
市盈率:13.57
高:12.05
開:11.83
低:11.69
收:11.75
資料載入中...
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

重要事件披露

Form 8-K - Current report